Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,318.32 +11.31 (+0.21%) Dow
39,479.53 -191.51 (-0.48%) Nasdaq
16,912.54 +111.00 (+0.66%) Bitcoin USD
68,007.15 -1,449.66 (-2.09%) CMC Crypto 200
1,471.30 -31.37 (-2.09%)
SHL Telemedicine Ltd. (SHLT)
- Business Wire
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
TEL AVIV, Israel & ZURICH & NEW YORK, May 21, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is proud to announce that it has expanded its offering in Israel to include the groundbreaking ability to perform at-home Biomarker blood tests.
- Business Wire
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
TEL AVIV, Israel & ZURICH, & NEW YORK, May 16, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is thrilled to announce that it recently officially launched it’s SmartHeart® membership program in the US.
- Business Wire
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
TEL AVIV, Israel & ZURICH & NEW YORK, April 17, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation.
